Fort Wayne Oncology & Hematology

Fort Wayne, Indiana 46845

1 studies enrolling now · 6 studies all time

What they study most

Cancer, Metastatic Pancreatic Cancer, Multiple Myeloma, Pancreatic Cancer, Prostate Cancer Metastatic, Urothelial Carcinoma

Studies at this site

• Master Rollover Protocol for Continued Safety Assessment of Study Drug — Available (expanded access)
• A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer — Completed
• A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma — Completed
• A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer — Completed
• A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer — Completed
• Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer — Completed